SCHEMBL4058523

SCHEMBL4058523

CNCc1ccccc1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
IDO1 P14902 2/20 0.45
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
KDM1A O60341 1/20 0.44
SLC6A4 P31645 7/20 0.44
SLC6A2 P23975 4/20 0.44
SLC6A3 Q01959 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
LTA4H P09960 1/20 0.44
HTR2A P28223 3/20 0.42
IFNAR1 P17181 1/20 0.42
MCL1 Q07820 1/20 0.41
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8016874 0.82 SLC6A4 (0.57) TAAR1KDM4ECYP3A4MAPTSLC6A4
SCHEMBL31265560 0.82 SLC6A4 (0.57) TAAR1KDM4ECYP3A4MAPTSLC6A4
SCHEMBL11268514 0.77 GAA (0.46) TAAR1IDO1KDM4EKDM1ASLC6A4
SCHEMBL2903629 0.77 TAAR1 (0.59) TAAR1IDO1KDM4ESLC6A2CYP1A2
SCHEMBL14391946 0.76 SLC6A4 (0.48) TAAR1KDM4ECYP3A4MAPTSLC6A4
SCHEMBL133921 0.76 CYP2D6 (0.48) TAAR1IDO1KDM4ECYP3A4KDM1A
SCHEMBL17161254 0.76 TAAR1 (0.52) TAAR1IDO1KDM4ECYP3A4MAPT
SCHEMBL11266118 0.76 BCHE (0.47) TAAR1IDO1CYP3A4KDM1ACYP1A2
SCHEMBL11161054 0.76 IDO1 (0.45) TAAR1IDO1KDM4EKDM1ACYP1A2
SCHEMBL31180009 0.76 TAAR1 (0.42) TAAR1IDO1CYP3A4KDM1ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed
CN-114956933-A Marker containing isotope oxygen atom and preparation method and application thereof 清华大学 2022-08-30 CN disclosed
EP-3087091-B1 VAR2CSA-DRUG CONJUGATES ZYMEWORKS INC (CA) 2021-10-20 EP disclosed
CN-110950812-B Triazole compound and application thereof in agriculture 东莞市东阳光农药研发有限公司 2020-11-10 CN disclosed
CN-110950812-A Triazole compound and application thereof in agriculture 东莞市东阳光农药研发有限公司 2020-04-03 CN disclosed
WO-2020063756-A1 TRIAZOLE COMPOUND AND USE THEREOF IN AGRICULTURE Dongguan HEC Pesticides R&D Co., Ltd. (CN) 2020-04-02 WO disclosed
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives H. LUNDBECK A/S (DK) 2009-07-30 US disclosed
US-7534791-B2 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2009-05-19 US disclosed
CN-101208324-A Benzo [ b ] furan and benzo [ b ] thiophene derivatives LUNDBECK & CO AS H (DK) 2008-06-25 CN disclosed
EP-1893596-A2 BENZOÝB¨FURANE AND BENZOÝB¨THIOPHENE DERIVATIVES H.Lundbeck A/S (DK) 2008-03-05 EP disclosed
WO-2007023395-A2 BENZO[B]FURANE AND BENZO[B]THIOPHENE DERIVATIVES H. LUNDBECK A/S (US) 2007-03-01 WO disclosed
US-20060287386-A1 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287386-A1 Benzo[b]furane and benzo[b]thiophene derivatives CYP1B1, TBCB, CYP4B1 TAAR1 1517/4885IDO1 3792/4885KDM4E 1255/4885
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives CYP1B1, TBCB, CYP4B1 TAAR1 1517/4885IDO1 3792/4885KDM4E 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.